Skip to content
FY'25FY'24FY'23FY'22
Returns
Return on equity-36.6%+2.5pp-39.1%+3.8pp-42.8%+0.6pp-43.5%-20.6pp
Return on assets-33%+2.6pp-35.6%+3.7pp-39.2%+1.7pp-41%-18.7pp
Return on invested capital-50.9%+11.1pp-62%-4.4pp-57.6%-10.1pp-47.5%
Liquidity
Current ratio10×-0.5×10.5×-1.8×12.3×-0.3×12.6×-19.6×
Quick ratio10×-0.5×10.5×-1.8×12.3×-0.3×12.6×-19.6×
Cash ratio0.9×-2.4×3.3×+0.2×3.2×+1.7×1.4×-0.1×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×
Debt-to-assets0.0×0.0×0.0×0.0×
Per Share
Book value per share$5.50-21.0%$6.96+24.1%$5.61+13.6%$4.94-31.4%
Valuation
Market capitalization$998.38M+253%$430.29M-44.0%$768.62M+681%$98.46M-73.6%
Enterprise value$946.79M+306%$292.24M-58.4%$702.5M+809%$77.32M-78.7%
Price / book2.1×+1.3×1.1×-2.0×+2.5×0.5×-0.8×
Earnings yield-18.5%+27.1pp-30.1%-17.5pp-12.6%+93.8pp-106.4%-87.4pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Olema Pharmaceuticals, Inc.'s ratios come from?
Every ratio is computed from Olema Pharmaceuticals, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.